KoreaTechDesk | Korean Startup and Technology News

Wed, October 22, 2025

Sign in

Virtual Demo Day
Menu
  • Home
  • Startup News
    • AI & Big Data
    • AR & VR
    • Blockchain
    • Clean Technology
    • Content & Games
    • Cybersecurity
    • Enterprise & SaaS
    • FinTech
    • Gadgets & Electronics
    • Health & Bio
    • Manufacturing
    • Press Release
    • IoT
    • Marketplaces & E-commerce
    • Robotics
    • Transportation
    • Investments
    • Ecosystem & Lists
  • Governments
    • Artificial Intelligence Industry Cluster Agency
    • Daegu Technopark
    • GANGNAM-GU
    • Gyeonggido Business & Science Accelerator
    • Hwaseong Industry Promotion Agency
    • Invest Seoul
    • Korea Creative Content Agency
    • Korea Internet & Security Agency
    • Korea Information Security Industry Association
    • Korea Institute of Startup & Entrepreneurship Development
    • Korea Tourism Organization
    • Korea Trade-Investment Promotion Agency
    • Ministry of Culture, Sports and Tourism
    • Ministry of SMEs & Startups
    • National IT Industry Promotion Agency
    • Pangyo Techno Valley
    • Seoul Business Agency
    • Seoul FinTech Lab
    • South Gyeongsang Province
    • Seoul Metropolitan Government
  • Events
    • COMEUP
    • Korea Fintech Week
    • K-Content Expo
    • NextRise
    • Try Everything
  • Interviews
    • Investors’ interviews
    • Founders’ interviews
  • Programs
    • Asan Voyager
    • CAPA Global Program
    • Campus Town Program
    • SGSC Global Bootcamp
    • Gangnam-gu Global Roadshow
    • Global SaaS Marketplace Support Project
    • LAUNCHPAD
    • COMEUP STARS 120
    • K-Startup Grand Challenge
    • TIPS X beSUCCESS Global Project
    • SFL Global Program
    • KTO Global Showcase
    • Yonsei Univ Global Class
    • KOSME Global Program
  • Partner With Us
    • Press Release
    • Startup Scouting
    • Business Agencies
    • Global Mentorship Program
    • Investment Opportunities
    • K-Scouter Program
  • Lists
  • Virtual Demo Day
  • Home
  • Startup News
    • AI & Big Data
    • AR & VR
    • Blockchain
    • Clean Technology
    • Content & Games
    • Cybersecurity
    • Enterprise & SaaS
    • FinTech
    • Gadgets & Electronics
    • Health & Bio
    • Manufacturing
    • Press Release
    • IoT
    • Marketplaces & E-commerce
    • Robotics
    • Transportation
    • Investments
    • Ecosystem & Lists
  • Governments
    • Artificial Intelligence Industry Cluster Agency
    • Daegu Technopark
    • GANGNAM-GU
    • Gyeonggido Business & Science Accelerator
    • Hwaseong Industry Promotion Agency
    • Invest Seoul
    • Korea Creative Content Agency
    • Korea Internet & Security Agency
    • Korea Information Security Industry Association
    • Korea Institute of Startup & Entrepreneurship Development
    • Korea Tourism Organization
    • Korea Trade-Investment Promotion Agency
    • Ministry of Culture, Sports and Tourism
    • Ministry of SMEs & Startups
    • National IT Industry Promotion Agency
    • Pangyo Techno Valley
    • Seoul Business Agency
    • Seoul FinTech Lab
    • South Gyeongsang Province
    • Seoul Metropolitan Government
  • Events
    • COMEUP
    • Korea Fintech Week
    • K-Content Expo
    • NextRise
    • Try Everything
  • Interviews
    • Investors’ interviews
    • Founders’ interviews
  • Programs
    • Asan Voyager
    • CAPA Global Program
    • Campus Town Program
    • SGSC Global Bootcamp
    • Gangnam-gu Global Roadshow
    • Global SaaS Marketplace Support Project
    • LAUNCHPAD
    • COMEUP STARS 120
    • K-Startup Grand Challenge
    • TIPS X beSUCCESS Global Project
    • SFL Global Program
    • KTO Global Showcase
    • Yonsei Univ Global Class
    • KOSME Global Program
  • Partner With Us
    • Press Release
    • Startup Scouting
    • Business Agencies
    • Global Mentorship Program
    • Investment Opportunities
    • K-Scouter Program
  • Lists
  • Virtual Demo Day
Home Startup Health & Bio

Kainos Medicine Demonstrates Long-Term Effectiveness of its AIDS Treatment Drug ACC008 in Phase 3 Clinical Trial

by KoreaTechDesk Writer
August 9, 2023
in Health & Bio, Pangyo Techno Valley
0
Kainos Medicine

(Image courtesy: Kainos Med)

Kainos Medicine, spearheaded by CEO Lee Ki-seop and renowned for its prowess in drug development, recently declared the successful culmination of its Phase 3 clinical trial for ACC008, an AIDS treatment medication. This trial was executed in China, in collaboration with their Chinese affiliate, Jiangsu Aidea, aimed at broadening market outreach.

This clinical trial holds immense significance as it’s a comprehensive study that benchmarks ACC008 against Genvoya, a medication formulated by Gilead. The study also validates that ACC008 can be an alternative for patients who have been on different treatments.

The trial, undertaken with 757 patients across 10 prominent clinical centers, including the Beijing Ditan Hospital linked with Capital Medical University, confirmed ACC008’s non-inferiority, effectiveness, and safety to Genvoya. Furthermore, it sustained viral suppression for an impressive 48 weeks.

ACC008 amalgamates three potent drugs: KM-023, TDF, and 3C3. In December 2022, the drug won approval (branded ‘Fubangde’, active ingredient ‘Ainuomiti’) from the Chinese Food and Drug Administration, cementing its reputation as an established anti-HIV treatment in China.

Following the guidelines set by the Chinese Center for Drug Evaluation (CDE), this Phase 3 trial utilized a randomized, double-blind structure targeting patients familiar with existing treatments. Moreover, a comparative non-inferiority test was executed against Genvoya, an AIDS medication covered by Chinese health insurance. ACC008’s clinical outcomes highlighted its potential to supersede other anti-HIV medications, facilitating enhanced patient compliance and elevating treatment outcomes and safety.

Once greenlighted for an extended patient demographic, ACC008 stands to offer a groundbreaking treatment alternative for AIDS patients resistant to conventional medications or those experiencing diminished treatment efficacy. This nod of approval could catapult ACC008 not just in the Chinese domain but on a global scale.

A spokesperson for Kainos Medicine elaborated, “The distinctive benefits of ACC008, as showcased in this trial, positions it to potentially dominate global markets, encompassing European territories and economically challenged nations. This past April, our international tech transfer agreement for our AIDS medication promises a surge in royalty sales.”

Kainos Medicine, stationed at Korea Bio Park in Pangyo Techno Valley, Seongnam-si, is a global pharma trailblazer, delving into novel drug innovations targeting brain disorders, cancer, and infectious ailments.

For inquiries and connections with Korean tech companies mentioned in this article,, contact us at [email protected]. We’re here to facilitate valuable partnerships.

Also Read,

  • LG Electronics to Launch $100 Million Global Startup Fund to Foster Innovation in Digital Healthcare & More
  • Seoul Metropolitan Govt Partners with ‘Elephant’ App to Enhance Citizen Welfare through Mental Health Services
  • Digital Healthcare startup CenacleSoft secures investment from Naver Cloud for its EMR platform
  • VUNO to collaborate with Latin American company Visual Medica for integrated medical solutions

Keep tab on latest news in the Korean startup ecosystem & follow us on  LinkedIN, Facebook, and Twitter for more exciting updates and insights.

Tags: ACC008AIDS Treatment DrugChinese Center for Drug EvaluationKainos Medicinekorear&dcityKorear&dhubkoreastartupcitykoreastartuphubPangyo Techno Valley
Previous Post

Institut Pasteur Korea Debuts Specimen Resource Bank for Global Infectious Disease Studies

Next Post

NHN Commerce Teams Up with Beijing Wenchuanban Development to Forge a Leading Global Retail Platform

Next Post
NHN Commerce Teams Up with Beijing Wenchuanban Development

NHN Commerce Teams Up with Beijing Wenchuanban Development to Forge a Leading Global Retail Platform

MOST READ ARTICLE OF THE WEEK

1.
Beyond 2025 National Audit: Korea’s MSS Bets on AI, Youth Founders, and Regional Venture Funds to Drive Inclusive Innovation
15 Oct 2025
2.
Korea Bets on Vertical AI: Rebellions and Lunit Collaborate to Expand Medical AI Ecosystem Globally
16 Oct 2025
3.
Korea’s Crypto Accountability Gap Widens as Dunamu, Bithumb Skip Third National Audit
16 Oct 2025
4.
Global ASTI 2025: Korea’s National R&D Network Charts New Path for AI Collaboration and Export Growth
17 Oct 2025
5.
Korea Builds Financial Backbone for Next-Gen K-Content Through KIBO – KB Kookmin Bank Partnership
17 Oct 2025
Register for Event

[the_ad id=”18508″]

List Article

1.
6 Reasons Why Seoul Is Poised to Become a Top 5 Global Economic Hub by 2030
20 Aug 2024
2.
Top Co-working Spaces for Startups & Companies to Explore in South Korea
3 Apr 2024
3.
Top Accelerators in South Korea Shaping Startup Success
29 Nov 2023
4.
Top Korean Venture Capital Firms Backing Startup Success
26 Oct 2023
5.
Top Apps for Seamless Korean to English Translation
14 Aug 2023

Similar Articles

Health & Bio

Greenish Taps Japan’s Biohealth Market with Inclusive Fertility Solutions, Securing Global Partner Interest

More
Health & Bio

From Policy Lag to Global Stage: How MSS Is Fast-Tracking Korea’s Biotech Ventures into Japan and the Nordics

More
AI & Big DataFounders' interviewsHealth & BioINTERVIEWSStartup

Pioneering Precision: How South Korea’s Galux is Redefining Antibody Discovery with AI

More

Topics

Menu
  • AI & Big Data
  • AR & VR
  • Blockchain
  • Clean Technology
  • Content & Games
  • Cybersecurity
  • Enterprise & SaaS
  • FinTech
  • Gadgets & Electronics
  • Health & Bio
  • IoT

Program

Menu
  • Asan Voyager
  • CAPA Global Program
  • SGSC Global Bootcamp
  • LAUNCHPAD
  • COMEUP STARS 120
  • K-Startup Grand Challenge
  • TIPS X beSUCCESS Global Project
  • SFL Global Program
  • KTO Global Showcase
  • Yonsei Univ Global Class
  • KOSME Global Program

About

Menu
  • About Us
  • all articles
  • Terms of Use
  • Privacy
  • Cookie-policy
  • twitter

Subscribe and be informed first hand about actual Korean startup news.

All the day’s headlines and highlights, direct to you every morning.

Contact us : [email protected]

Topics

Menu
  • AI & Big Data
  • AR & VR
  • Blockchain
  • Clean Technology
  • Content & Games
  • Cybersecurity
  • Enterprise & SaaS
  • FinTech
  • Gadgets & Electronics
  • Health & Bio
  • IoT

Program

Menu
  • Asan Voyager
  • CAPA Global Program
  • SGSC Global Bootcamp
  • LAUNCHPAD
  • COMEUP STARS 120
  • K-Startup Grand Challenge
  • TIPS X beSUCCESS Global Project
  • SFL Global Program
  • KTO Global Showcase
  • Yonsei Univ Global Class
  • KOSME Global Program

About

Menu
  • About Us
  • all articles
  • Terms of Use
  • Privacy
  • Cookie-policy
  • twitter

Subscribe and be informed first hand about actual Korean startup news.

All the day’s headlines and highlights, direct to you every morning.

© 2023 Koreantech News & Media Korea Zrt. All rights reserved.

Our Spring Sale Has Started

You can see how this popup was set up in our step-by-step guide: https://wppopupmaker.com/guides/auto-opening-announcement-popups/

Our Spring Sale Has Started

You can see how this popup was set up in our step-by-step guide: https://wppopupmaker.com/guides/auto-opening-announcement-popups/

We hope you enjoy our content, May you please give us Feedback regarding our website!

Single Post Feedback

dgdfgfdgdf

What you think about Koreatechdesk, Share your idea with us!

feedback popup

Invitation submission has been closed

Insert/edit link

Enter the destination URL

Or link to existing content

    No search term specified. Showing recent items. Search or use up and down arrow keys to select an item.